Our Board of Councilors is the school’s premier group of strategic advisers to the dean. Board members serve as advocates and ambassadors for the school and our mission, locally and globally. Esteemed leaders in their fields—ranging from business and philanthropy to academia and healthcare—our board members’ diverse experiences and community involvement make them assets to both the school and the university.
David W. Neu, MBA, is executive chairman of Ananda Health, a diversified healthcare organization. He previously was president of AmerisourceBergen Drug Corporation and Good Neighbor Pharmacy, one of the largest global pharmaceutical sourcing and distribution services companies. In 2010, Neu and his wife, Esperanza, co-founded the Neu Family Foundation to support causes related to health and education. They were recognized as Philanthropists of the Year by the Association of Fundraising Professionals of Greater Philadelphia.
Edward Abrahamian is a USC alumnus who earned his bachelor’s degree in architecture in 1963. His older brother, Frank Abrahamian, graduated with a doctorate from the pharmacy school in 1959. After training as an architect at USC, Abrahamian worked for several Los Angeles-area firms before launching his own architecture and interior design company in Pasadena. When Abrahamian launched his own firm, he had built a broad client base. The company quickly grew into a 40-person outfit known as AP&T, short for Abrahamian, Pagliasotti & Tanaka. He oversaw projects throughout Southern California and the western U.S., from department stores to celebrity estates.
Anil “Neil” Badlani is the founder, former CEO and current board member of HealthSpecialty, an FDA-certified drug and cGMP compliant 34,000 square-foot facility located in Santa Fe Springs that specializes in the product development and manufacturing of skin, hair and body care products as well as color cosmetics. He is a 2010 graduate of the USC Marshall School of Business.
Melvin F. Baron, PharmD ’57, MPA, served on the school’s faculty for four decades, directing the PharmD/MBA program and teaching clerkships in pharmacy administration/entrepreneurship and healthcare needs of special populations. Through his Health Literacy Program, which produces fotonovelas and audiovisual novelas in both English and Spanish, more than half a million booklets have been distributed at safety-net clinics, health fairs and pharmacies, providing information to at-risk populations in a culturally sensitive way.
Gale Bensussen, JD, is CEO at Doctor’s Best and was a founding partner and president of Leiner Health Products. An experienced CEO with a demonstrated history of working in the consumer goods industry, he has more than 40 years of experience in the vitamin, minerals and supplement industry. He is a graduate of the USC Marshall School of Business and the Southwestern School of Law.
Danielle C. Colayco, PharmD ’08, MS Pharmaceutical Economics and Policy ’10, is executive director of the Komoto Family Foundation, a nonprofit organization that helps under-resourced communities access social support and pharmacist-provided healthcare through assistance programs, health education and community-based research.
Daniel Gil, PhD, is a leader in pharmaceutical research and early-stage clinical development in the areas of ophthalmology, neuroscience and dermatology. He founded CELLerity Consulting, a pharmaceutical and biotechnology firm specializing in early-stage drug development. He worked at Allergan for 30 years, serving as vice president, research technologies and portfolio and overseeing the progression of internal research programs and clinical development across the company’s therapeutic areas.
Debrina Johnson, PharmD ’13, who is board-certified in both geriatric and ambulatory care, currently serves as a contract clinical pharmacist for Arine, a health technology start-up, where she streamlines complex medication regimens for clients. Following graduation from USC, she served as a community pharmacist and pharmacy manager at Albertsons where she began teaching clinically as a preceptor for pharmacy students from Western University of Health Sciences and Loma Linda University. She has also served as an adjunct professor at the University of La Verne and at Keck Graduate Institute. A past president of the Inland Empire Pharmacist Association, she is actively involved with various local, state and national pharmacy associations. Her research interests include underserved patient populations, substance use disorders and managing mental health and behavioral health conditions in the longitudinal context.
Dong Koo (D.K.) Kim is founder of BP Industries Inc., a company specializing in the international trade of consumer products. Kim donated $5 million to the International Center for Regulatory Science, which was renamed the D.K. Kim International Center for Regulatory Science in his honor. The gift established the Kim Integrated Health Management Initiative, which is designed to heighten the school’s global impact, ensuring greater access to healthcare among underserved communities in partnership with diverse organizations in the U.S. and abroad.
Dr. Dianne Kwock, PharmD, is the co-founder and president of Fox Drugs, Inc. As president of Fox Drugs, Inc. for more than 40 years, Dr. Kwock owns a network of four independent pharmacies, including one in a rural, non-English speaking community. Fox Drugs’ most recent development provides comprehensive pharmacy services to assisted living facilities while emphasizing preventive, pharmaceutical care. She graduated with a doctorate of pharmacy in 1974 from USC Mann.
Ann Young Lee is CEO and co-founder of Community Organized Relief Effort (CORE), an evolution of Sean Penn’s J/P HRO, an organization founded in 2010 geared towards reconstruction and relief efforts in Haiti. Amid the COVID-19 pandemic, Ms. Lee has overseen the expansive growth of the organization’s response efforts, which began in Los Angeles and quickly developed into an exemplary nationwide program of testing sites providing free testing, specifically targeting vulnerable and underserved communities affected by the disease. She has 20 years of experience managing large-scale humanitarian response and sustainable development programming across a variety of sectors. She is a graduate of NYU and Johns Hopkins University School of Advanced International Studies (SAIS).
Vinson Lee, PharmD, MS, FCPhA, FAMCP is currently Vice President of Market Access at Coherus Biosciences, a biopharmaceutical company focused on expanding patient access to important, cost-effective medicines, and delivering significant savings to the U.S. healthcare system. Dr. Lee has over 16 years of experience in managed care pharmacy, the pharmaceutical industry, consulting, and academia. He has held various commercial market access, medical affairs, and HEOR leadership roles within the pharmaceutical industry. His experience includes developing and implementing market access strategies and services for product coverage, directing value-based contract negotiations, and presenting key clinical and pharmacoeconomic data to formulary decision makers and health systems to ensure brand access. In addition, he has broad therapeutic area experience across oncology, rheumatology, dermatology, ophthalmology, and biosimilars.
He is actively involved within the pharmacy profession and associations, currently serving as a Director for the Academy of Managed Care Pharmacy (AMCP) and adjunct assistant professor of pharmacy at USC Mann. He is also a past President and Speaker of the House for the California Pharmacists Association (CPhA) and served on the USC Alumni Association Board of Governors representing the school.
He holds a Doctor of Pharmacy degree from USC School of Pharmacy, Master of Science degree in Cell & Neurobiology from the Keck School of Medicine of USC, and Bachelor of Science in Biology from the University of California, Riverside.
Sohail Masood, PharmD ’08, is president, chairman and CEO at KabaFusion, a home infusion company with seven pharmacies nationwide. He previously founded several other businesses, including MAAS Medical, a medical device manufacturing company that was sold to Baxter in 2007, and Crescent Healthcare, a home infusion company that was sold to Walgreens in 2011.
David Meek is chief executive officer (CEO) and board member of Mirati Therapeutics, a clinical-stage biotechnology company focused on bringing forward therapies that address areas of high unmet need, including lung cancer. He has over 30 years of industry experience, where he held various global executive leadership positions in large pharmaceutical and commercial-stage biotechnology companies focused on oncology, including as CEO of Ipsen, a leading global biopharmaceutical company. He has also served on the boards of Pharmaceutical Research and Manufacturers of America (PhRMA), European Federation of Pharmaceutical Industries and Associations (EFPIA), and currently serves on the boards of uniQure N.V., and Entasis Therapeutics Holdings Inc.
Kimberly Moore, PharmD ’16, MS Healthcare Decision Analysis ’16, joined Edwards Lifesciences in 2016 where she was a member of the Global Health Economics and Reimbursement (Market Access) team. During her five-year tenure, she developed an expertise in real-world evidence, outcomes research and medical device market access. She was responsible for the real-world evidence strategy and execution for the transcatheter aortic valve replacement business. In 2021, she joined AbbVie as a Medical Outcomes Science Liaison, working as the scientific expert for regional decision makers in California, Hawaii and Nevada. She covers the entire AbbVie portfolio with expertise in immunology, oncology, virology, neurology, psychiatry, dermatology, rheumatology, gastroenterology, ophthalmology, and an extensive pipeline. She also practices as a per-diem community pharmacist where she maintains her clinical expertise and provides vaccine, travel and contraceptive services and is frequently tapped as an expert witness for community pharmacy litigation. In addition to serving on the USC Mann Board of Councilors, Moore serves on the USC Alumni Association Board of Governors, representing USC Mann.
Shushma Patel, MBA, RPh is a pharmacist and owner of The Prescription Shop, an independent pharmacy in Montebello. Born in Tanzania and raised in London, England, she graduated as a pharmacist from the Brighton School of Pharmacy in Sussex, England in 1985. When an opportunity arose to work in California with Osco Drugs, she grabbed it with both hands and never looked back. Throughout a whirlwind 22-year tenure, she rode a wave of successive corporate mergers with Sav-On, Albertson’s and CVS Caremark, on the way picking up recognition awards for delivering breakthrough achievements managing both front-end and pharmacy operations as a district pharmacy manager for a 65-store business portfolio. A current advisory board member of the Indian Pharmacists Association, she is an enthusiastic proponent of spreading healthcare literacy, particularly amongst community members at risk of diabetes and cardiovascular ailments.
Chao Peng is Chief Financial Officer of Freeze Holdings (China). As CFO, she is responsible for supervising and managing the company’s strategic development, pre-investment evaluation and post-investment management of various investment projects. Previously, as Branch General Manager of Centaline (China) Property Consultants Co. Ltd., she was responsible for the planning and marketing management of dozens of real estate projects and transactions as well as the company’s business expansion in mainland China.
William Pih, PharmD ’83, is principal at Two Labs, a pharmaceutical consulting company that helps clients bring products to market. Pih also founded BioSys Laboratories, a medical device company focused on in-vitro diagnostic devices and other medical and laboratory products.
Robert Popovian, PharmD ’93, MS Pharmaceutical Economics and Policy ’96, is the founder of Conquest Advisors and Chief Science Policy Officer at Global Living Foundation and has more than two decades of experience in healthcare policy, economics and medical affairs. He has published and presented extensively on issues related to healthcare costs and clinical outcomes, including authorship in clinical and healthcare delivery journals. Popovian has a regular column in Morning Consult.
Denis Portaro, PharmD ’71, JD, is the CEO of Dendrax LLC, a company he and his wife, Sandy, founded in 1997. Previously, he served as president of Portaro Pharmacies Inc., which he sold in 1997. He is a former chair of the school’s Board of Councilors and a former member of the USC Alumni Association Board of Governors. Portaro received his juris doctor from Kaplan University.
Raymond Risman, PharmD ’07, MS ’07, is currently the vice president of trade relations and pharmaceutical contracting at Mark Cuban Cost Plus Drug Company. He focuses on lowering the cost of branded prescription medications to provide broader access, flexibility and affordability for the underinsured population. Risman received his PharmD and Master’s in Regulatory Science degrees from USC Mann. Previously at the industry relations group at OptumRx, Risman led efforts to negotiate Medicare contracts and managed Medicaid and other commercial rebate programs with pharmaceutical manufacturers. Additionally, Risman has extensive experience in market access strategies, product development and customer engagement.
Risman also worked with the L.A. County Department of Health Services supporting central pharmacy administration for hospitals and clinics. During his tenure with the department, he oversaw system-wide formulary changes, including the development and implementation of physician, nursing and pharmacy staff training and education.
Jacque J. Sokolov, MD, is chair and CEO of SSB Solutions, a nationally recognized consulting group working collaboratively with healthcare clients to develop physician-driven, value-focused strategies in rapidly evolving markets. After receiving his MD degree from the Keck School of Medicine of USC, he completed his internal medicine residency at the Mayo Graduate School of Medicine and a fellowship in cardiovascular diseases from the University of Texas-Southwestern Medical School. Sokolov has had the opportunity to serve as board director, corporate officer and adviser in multiple healthcare sectors.
Ken Thai, PharmD ’02, is CEO of 986 Degrees Corporation, a pharmacy franchise, and was president of the California Pharmacists Association for 2019–20. He also serves as an adjunct assistant professor of pharmacy practice at USC Mann, precepting and mentoring students interested in becoming entrepreneurs in pharmacy. After earning his doctor of pharmacy degree, he completed a residency in community pharmacy practice at USC. He owns multiple retail independent pharmacies throughout Southern California, Nevada and Texas.
Kelly Wilder is executive vice president of strategic business development for Precision Value & Health and co-president of Precision for Value. Her market engagement extends to leading organizations such as the Academy of Managed Care Pharmacy, where she served on the Healthcare Economic Information and Preapproval Information Exchange Committee. Prior to joining Precision, Wilder managed the business development efforts of an oncology-focused market research organization and led the account and project teams of a New York City-based medical communications agency.
William Austin Heeres, PharmD ’63, owned several pharmacies in Riverside, Calif. In addition to his longtime tenure on the board, he has served as a committed mentor to numerous students over the years. In 2002, he and his wife, Josephine, established the William A. and Josephine A. Heeres Chair in Community Pharmacy.